	US 12,472,236 B2
	Compositions and methods for treating diabetes
John Docherty, Port Perry (CA); and Christopher Andrew Bunka, Kelowna (CA)
Assigned to POVIVA CORP, Carson City, NV (US)
Filed by POVIVA CORP, Carson City, NV (US)
Filed on Dec. 3, 2024, as Appl. No. 18/967,455.
Claims priority of provisional application 63/622,696, filed on Jan. 19, 2024.
Claims priority of provisional application 63/617,759, filed on Jan. 4, 2024.
Claims priority of provisional application 63/605,701, filed on Dec. 4, 2023.
Prior Publication US 2025/0177314 A1, Jun. 5, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/26 (2006.01); A61K 9/48 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01); A61K 47/28 (2006.01); A61K 47/44 (2017.01); A61P 3/10 (2006.01)

CPC A61K 38/26 (2013.01) [A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 9/4875 (2013.01); A61K 47/02 (2013.01); A61K 47/26 (2013.01); A61K 47/28 (2013.01); A61K 47/44 (2013.01); A61P 3/10 (2018.01)]

18 Claims

1. A composition, comprising:

a) from about 0.2 mg to about 25 mg of liraglutide;

b) from about 0.4 mg to about 50 mg of olive oil;

c) from about 0.05 mg to about 5 mg of deoxycholic acid;

d) from about 1 mg to about 460 mg of sodium bicarbonate; and

e) from about 3 mg to about 480 mg of mannitol, colloidal silicon dioxide, or mixtures thereof.